Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POLARIS-ACS: Pemafibrate and Coronary Plaque in Acute Coronary Syndrome
jRCTs051190100Recruiting
- Sponsor
- Kowa Company, Ltd.
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of pemafibrate in acute coronary syndrome (ACS), sponsored by Kowa Company, Ltd. Primary endpoint: Change in non-culprit coronary plaque characteristics. Started Jan 2020; status: recruiting.
02
Drugs
pemafibrate
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on jRCTs051190100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051190100.